Literature DB >> 6645626

Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979.

C M Beard, S G Sheps, L T Kurland, J A Carney, J T Lie.   

Abstract

For the 30 years from 1950 through 1979, the population of Rochester, Minnesota, averaged 45,800, resulting in almost 1.4 million person-years of observation. During that time, 11 cases of pheochromocytoma were diagnosed in this population; thus, the average annual incidence rate was 0.8 per 100,000 person-years. With the inclusion of two additional diagnosed familial cases, the incidence rate would be 0.95 per 100,000 person-years. Five of the 11 cases were diagnosed initially at autopsy.

Entities:  

Mesh:

Year:  1983        PMID: 6645626

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  103 in total

1.  Potential problems in the use of necropsy data in epidemiologic research.

Authors:  E J Boyko
Journal:  J Gen Intern Med       Date:  1990 Nov-Dec       Impact factor: 5.128

2.  ACP Broadsheet No 127: April 1991. Measurement of catecholamines and their metabolites in urine.

Authors:  C Weinkove
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

3.  Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Mouhammed A Habra; Thereasa Rich; Paxton V Dickson; Nancy Perrier; Alexandria Phan; Steven Waguespack; Shreyaskumar Patel; Camilo Jimenez
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

Review 4.  Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

Authors:  Roland Därr; Matthias Kuhn; Christoph Bode; Stefan R Bornstein; Karel Pacak; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 5.  The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review.

Authors:  Juan P Brito; Noor Asi; Michael R Gionfriddo; Catalina Norman; Aaron L Leppin; Claudia Zeballos-Palacios; Chaitanya Undavalli; Zhen Wang; Juan P Domecq; Gabriela Prustsky; Tarig A Elraiyah; Larry J Prokop; Victor M Montori; Mohammad Hassan Murad
Journal:  Endocrine       Date:  2015-02-06       Impact factor: 3.633

6.  Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty.

Authors:  Margarita Raygada; Kathryn S King; Karen T Adams; Constantine A Stratakis; Karel Pacak
Journal:  J Pediatr Endocrinol Metab       Date:  2014-09       Impact factor: 1.634

7.  Clinically silent chromaffin-cell tumors: Tumor characteristics and long-term prognosis in patients with incidentally discovered pheochromocytomas.

Authors:  S Grozinsky-Glasberg; A Szalat; C A Benbassat; A Gorshtein; R Weinstein; D Hirsch; I Shraga-Slutzky; G Tsvetov; D J Gross; I Shimon
Journal:  J Endocrinol Invest       Date:  2010-05-17       Impact factor: 4.256

8.  AZD8055 inhibits ACTH secretion in a case of bilateral ACTH-secreting pheochromocytoma.

Authors:  Fen Wang; Anli Tong; Chunyan Li; Yunying Cui; Jian Sun; Ailing Song; Yuxiu Li
Journal:  Oncol Lett       Date:  2018-07-25       Impact factor: 2.967

9.  Uncommon presentation, rare complication and previously undescribed oncologic association of pheochromocytoma; the great masquerader.

Authors:  David Lawrence; Kevan Salimian; Thorsten Leucker; Seth Martin
Journal:  BMJ Case Rep       Date:  2018-04-05

Review 10.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.